兴齐眼药：公司不同浓度硫酸阿托品滴眼液目前正处于审评阶段

Core Viewpoint - The company is currently in the review stage for different concentrations of atropine sulfate eye drops (0.02% and 0.04%), which aim to better meet the needs of various myopic populations for myopia control [1] Group 1 - The company has stated that it will fulfill its information disclosure obligations in a timely and accurate manner once the products meet the disclosure standards [1] - The different concentrations of atropine sulfate eye drops are designed to cater to the varying needs of myopia control among different groups [1]